Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines

NCT02303002 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
268
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Revance Therapeutics, Inc.